Columbia P&S 2014
| Purine synthesis inhibitor | ||
| Calcineurin inhibitor | ||
| calcineurin inhibitor | ||
| mTor inhibitor | ||
| Nephrotoxicity, CV disease. | ||
| Block mTor, thereby preventing transmission of IL-2 proliferative signal in TC. | ||
| Prevent IL-2 secretion, the major proliferative signal | ||
| Calcineurin inhibitors (cyclosporine, tacrolimus) | ||
| Sevelamer, CaCO3, Calcium acetate | ||
| Autosomal dominant | ||
| VDRA (vitamin d receptor activators) | ||
| Diffusion | ||
| Convection / Ultrafiltration | ||
| Erythropoietin (epoetin alpha) | ||
| Phosphate binders and vitamin B complex vitamins. |

